ONPREFA Trademark

Trademark Overview

On Tuesday, June 27, 2023, a trademark application was filed for ONPREFA with the United States Patent and Trademark Office. The USPTO has given the ONPREFA trademark a serial number of 98060406. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 25, 2024. This trademark is owned by Avenue Therapeutics, Inc.. The ONPREFA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain; Pharmaceutical preparations for the treatment of pain by intravenous or intramuscular delivery; Pharmaceutical preparations for the treatment of pain by intravenous delivery for prevention, treatment and alleviation of postoperative pain; Pain relief medication; Tramadol; Prescription medicine, namely, a prescription synthetic narcotic analgesic; Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, preparations for the prevention and treatment of pain; Pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, preparations for the treatment of acute critical care conditions in the nature of traumatic brai...
onprefa

General Information

Serial Number98060406
Word MarkONPREFA
Filing DateTuesday, June 27, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, June 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the prevention, treatment and alleviation of pain; Pharmaceutical preparations for the treatment of pain by intravenous or intramuscular delivery; Pharmaceutical preparations for the treatment of pain by intravenous delivery for prevention, treatment and alleviation of postoperative pain; Pain relief medication; Tramadol; Prescription medicine, namely, a prescription synthetic narcotic analgesic; Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, preparations for the prevention and treatment of pain; Pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, preparations for the treatment of acute critical care conditions in the nature of traumatic brain injury, lung disorders, respiratory failure, heart failure, stroke, low cardiac output syndrome, septic shock, traumatic brain injury, kidney failure, tissue ischemia, burns, wounds, and traumatic injuries to the head and body

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 28, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAvenue Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453
Party NameAvenue Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Trademark Events

Event DateEvent Description
Friday, June 30, 2023NEW APPLICATION ENTERED
Friday, July 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 13, 2024ASSIGNED TO EXAMINER
Tuesday, March 26, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 30, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 25, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

onprefa pharmaceutical preparations treatment pain prevention medical namely alleviation scientific prescription